Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lovise Maehle

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 22, 2005
[Hereditary breast cancer]Pål Møller, Lovise Maehle, Jaran Apold
Hereditary Cancer in Clinical Practice|September 4, 2009
No sib pair concordance for breast or ovarian cancer in BRCA1 mutation carriersPål Møller, Lovise Maehle, Neal Clark, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancerAstrid T Stormorken, Neal Clark, Eli Grindedal, et al.
Hereditary Cancer in Clinical Practice|April 16, 2009
Survival in Norwegian BRCA1 mutation carriers with breast cancerAnne Irene Hagen, Steinar Tretli, Lovise Maehle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2008
Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysisJan Norum, Anne Irene Hagen, Lovise Maehle, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 21, 2006
Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutationAmy Østertun Geirdal, Lovise Maehle, Ketil Heimdal, et al.
Familial Cancer|June 14, 2005
Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutationsAmy Østertun Geirdal, Jon G Reichelt, Alv A Dahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriersLovise Maehle, Jaran Apold, Torbjørn Paulsen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2007
Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriersPål Møller, Anne Irene Hagen, Jaran Apold, et al.
Familial Cancer|October 9, 2008
High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriersEli Marie Grindedal, Ignacio Blanco, Astrid Stormorken, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 22, 2005
[Hereditary breast cancer]Pål Møller, Lovise Maehle, Jaran Apold
Hereditary Cancer in Clinical Practice|September 4, 2009
No sib pair concordance for breast or ovarian cancer in BRCA1 mutation carriersPål Møller, Lovise Maehle, Neal Clark, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancerAstrid T Stormorken, Neal Clark, Eli Grindedal, et al.
Hereditary Cancer in Clinical Practice|April 16, 2009
Survival in Norwegian BRCA1 mutation carriers with breast cancerAnne Irene Hagen, Steinar Tretli, Lovise Maehle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2008
Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysisJan Norum, Anne Irene Hagen, Lovise Maehle, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 21, 2006
Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutationAmy Østertun Geirdal, Lovise Maehle, Ketil Heimdal, et al.
Familial Cancer|June 14, 2005
Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutationsAmy Østertun Geirdal, Jon G Reichelt, Alv A Dahl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriersLovise Maehle, Jaran Apold, Torbjørn Paulsen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 19, 2007
Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriersPål Møller, Anne Irene Hagen, Jaran Apold, et al.
Familial Cancer|October 9, 2008
High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriersEli Marie Grindedal, Ignacio Blanco, Astrid Stormorken, et al.
Pageof 5